Navigation Links
Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
Date:9/14/2007

-Submission initiates 90-day review period-

SOUTH SAN FRANCISCO, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has submitted a comprehensive data report relating to XL880 to GlaxoSmithKline (GSK). As announced in August 2007, GSK requested to initiate its review of XL880 before the compound reaches proof-of-concept as defined under the product development and commercialization agreement between the two companies. GSK now has 90 days to review the data package and determine if it will select the compound for further clinical development and commercialization.

"Both GSK and Exelixis have been very encouraged by the results seen to date in the comprehensive clinical program for XL880," said George A. Scangos, Ph.D, president and chief executive officer of Exelixis, Inc. "We have seen very encouraging signs of anti-tumor activity, and XL880 remains the only MET inhibitor for which there is human pharmacodynamic data demonstrating that the compound does inhibit MET in human tumors. The increasing recognition that MET is likely to play a role in the proliferation of many types of solid tumors, including lung, breast, and colon tumors, coupled with the demonstrated ability of XL880 to inhibit MET in humans, has generated considerable enthusiasm. We are pleased that GSK asked to review the data early in order to clarify ownership of the compound and expand XL880's position as what we believe is the most advanced MET inhibitor in clinical development."

Pursuant to the product development and commercialization agreement between Exelixis and GlaxoSmithKline, GlaxoSmithKline has the option, after completion of clinical proof-of-concept by E
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Due diligence and corporate clean-up
2. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
3. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
6. Versatile Reporter Vectors for Monitoring Viral Transduction
7. In Vivo Signal Transduction Pathway Reporting Systems
8. Improved Vectors for PathDetect Trans-Reporting Systems
9. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
10. Cis-Reporting System Monitors Intracellular Calcium Mobilization
11. Cis-Reporting System Monitors Intracellular Calcium Mobilization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... (PRWEB) October 30, 2014 The report ... Chemicals), by Application (Cosmetics & Toiletries, and Soaps & ... to 2019”, has defined and segmented the Fragrance Ingredients ... trends in terms of value. The market has been ... North America, Europe, Asia-Pacific, Latin America, and Rest of ...
(Date:10/30/2014)... 29, 2014 Global polyvinyl chloride (PVC) ... economic crisis during 2008-2009, especially in North America and ... currently is keeping to a growing trend. , The ... utilized in the construction segment. In 2013, the key ... tubing, sheets and rigid film. Moreover, the PVC was ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 ... collaboration provider, offers Office 365 end users the ... a complete phone system by adding voice enablement ... (O365) includes Lync Online, a communication tool that ... calls. With hosted voice, O365 becomes a comprehensive ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Spartan Bioscience ... Spartan RX CYP2C19 System . It detects CYP2C19 genetic ... cheek swab. , The Spartan RX CYP2C19 System is ... has been approved in Canada. Due to the system’s ... may be used by healthcare professionals such as doctors, ...
Breaking Biology Technology:Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 2Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 3Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 4Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 5Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 3Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3
(Date:10/31/2014)... synchrotron source that emits over a wide part of ... is currently being built in Lund, Sweden. The MAX ... the team putting together its component parts in a ... circumference of just a few hundred metres. Nevertheless, if ... new class of experiments that require source brightness and ...
(Date:10/31/2014)... Melbourne researchers have uncovered key steps involved in programmed ... diseases including lupus, cancers and neurodegenerative diseases. , ... Institute worked together to discover the three-dimensional structure of ... the first steps in how it causes cell death. ... and Proceedings of the National ...
(Date:10/30/2014)... a $1.04 million grant from the U.S. Army ... osteoarthritis using a patient,s own stem cells, spurred ... polymers., Liping Tang, a bioengineering professor and interim ... is primarily focused on helping soldiers who are ... if we inject microscaffolding that we,ve developed into ...
Breaking Biology News(10 mins):A new generation of storage -- ring 2A matter of life and death: Cell death proteins key to fighting disease 2UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2
... Research(R), a revolutionary biometric media research firm specializing ... of Andre Marquis as Senior Vice President of ... for expanding Innerscope,s offering into the growing digital ... innovative digital initiatives for start-ups and Fortune 500 ...
... the world are building an extensive repository of genetically ... function of the approximately 57,000 genes that make up ... Genomics Consortium recently announced the public availability of more ... about half of the known functional genes mapped for ...
... 2009 Despite a down economy, Safeway Inc. presented ... at the Translational Genomics Research Institute (TGen). Dan ... stores throughout Arizona, thanked the grocery chain,s customers and ... very proud to donate to such an organization as ...
Cached Biology News:Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing 2200,000 rice mutants available worldwide for scientific investigation 2Safeway gives $685,000 to TGen for breast cancer research 2
... Optimal Microdissection , CapSure HS and CapSure ... rapid extraction of populations of pure cells ... Laser Capture Microdissection., Ensure the Integrity ... , All CapSure LCM Caps have a ...
... Precision-designed for Optimal Microdissection , ... enable the precise and rapid extraction of ... and cytology samples with Laser Capture Microdissection., ... for Downstream Molecular Analysis , All CapSure ...
... the method of choice for thousands of ... instrument to offer both LCM and Laser ... Laser Cutting provides unprecedented speed and ... large numbers of cells. , LCM ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
Biology Products: